BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 33856473)

  • 1. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
    Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
    JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
    Gentilini OD; Botteri E; Sangalli C; Galimberti V; Porpiglia M; Agresti R; Luini A; Viale G; Cassano E; Peradze N; Toesca A; Massari G; Sacchini V; Munzone E; Leonardi MC; Cattadori F; Di Micco R; Esposito E; Sgarella A; Cattaneo S; Busani M; Dessena M; Bianchi A; Cretella E; Ripoll Orts F; Mueller M; Tinterri C; Chahuan Manzur BJ; Benedetto C; Veronesi P;
    JAMA Oncol; 2023 Nov; 9(11):1557-1564. PubMed ID: 37733364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Oncologists' Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor-Positive Breast Cancer.
    Minami CA; Bryan AF; Freedman RA; Revette AC; Schonberg MA; King TA; Mittendorf EA
    JAMA Netw Open; 2022 Aug; 5(8):e2228524. PubMed ID: 36001314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
    Ong C; Blue CM; Khan J; Deng X; Bandyopadhyay D; Louie RJ; McGuire KP
    Ann Surg Oncol; 2024 Jan; 31(1):335-343. PubMed ID: 37831277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing omission of radiation therapy and sentinel node biopsy in elderly patients with early stage, hormone-positive breast cancer.
    Christian N; Heelan Gladden A; Friedman C; Gleisner-Patton A; Murphy C; Kounalakis N; Ahrendt G
    Breast J; 2020 Feb; 26(2):133-138. PubMed ID: 31448508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
    McKevitt E; Cheifetz R; DeVries K; Laws A; Warburton R; Gondara L; Lohrisch C; Nichol A
    Ann Surg Oncol; 2021 Oct; 28(11):5950-5957. PubMed ID: 33817760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Mann JM; Wu X; Christos P; Nagar H
    Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Perspectives on Treatment Options for Older Women With Hormone Receptor-Positive Breast Cancer: A Qualitative Study.
    Wang T; Mott N; Miller J; Berlin NL; Hawley S; Jagsi R; Dossett LA
    JAMA Netw Open; 2020 Sep; 3(9):e2017129. PubMed ID: 32960279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
    Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
    JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer.
    Thompson J; Le J; Hop A; Melnik M; Paulson J; Wright GP
    Ann Surg Oncol; 2021 Oct; 28(10):5716-5722. PubMed ID: 34333704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
    Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
    JAMA Netw Open; 2021 Jun; 4(6):e2114904. PubMed ID: 34190995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional Recurrence Risk Following a Negative Sentinel Node Procedure Does Not Approximate the False-Negative Rate of the Sentinel Node Procedure in Breast Cancer Patients Not Receiving Radiotherapy or Systemic Treatment.
    Roos MM; van Steenhoven JEC; Aalders KC; Schreuder K; Burgmans JPJ; Siesling S; Elias S; van Dalen T
    Ann Surg Oncol; 2019 Feb; 26(2):372-378. PubMed ID: 30387028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer.
    Tamirisa N; Lin H; Shen Y; Shaitelman SF; Sri Karuturi M; Giordano SH; Babiera G; Bedrosian I
    JAMA Oncol; 2020 Oct; 6(10):1548-1554. PubMed ID: 32672820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
    Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
    JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
    Mamtani A; Patil S; Stempel MM; Morrow M
    Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.
    Haffty BG; McCall LM; Ballman KV; Buchholz TA; Hunt KK; Boughey JC
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):174-182. PubMed ID: 31085287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?
    Sun J; Mathias BJ; Sun W; Fulp WJ; Zhou JM; Laronga C; Loftus LS; Lee MC
    Ann Surg Oncol; 2021 Jan; 28(1):320-329. PubMed ID: 32613363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.
    Servy A; Maubec E; Sugier PE; Grange F; Mansard S; Lesimple T; Marinho E; Couturaud B; Girod A; Albert S; Dendale R; Calitchi E; Sarda L; Chanal J; Deschamps L; Sastre-Garau X; Laroche L; Crickx B; Avril MF
    Ann Oncol; 2016 May; 27(5):914-9. PubMed ID: 26811346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.